Safety and tolerability meta-analysis of aripiprazole in schizophrenia

被引：0
|
作者：
Carson, WH [1 ]
Stock, E [1 ]
Saha, AR [1 ]
Ali, MW [1 ]
McQuade, RD [1 ]
Kujawa, MJ [1 ]
Ingenito, G [1 ]
机构：
[1] Bristol Myers Squibb Co, Wallingford, CT 06492 USA
来源：
EUROPEAN PSYCHIATRY | 2002年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：106S / 106S
页数：1
相关论文
共 50 条
  • [21] Effectiveness and Tolerability of Aripiprazole in Children and Adolescents with Tourette's Disorder: A Meta-Analysis
    Liu, Yueying
    Ni, Hong
    Wang, Chunhong
    Li, Lili
    Cheng, Zaohuo
    Weng, Zhen
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2016, 26 (05) : 436 - 441
  • [22] Long-term safety and tolerability of aripiprazole lauroxil in patients with schizophrenia
    Nasrallah, Henry A.
    Aquila, Ralph
    Du, Yangchun
    Stanford, Arielle D.
    Claxton, Amy
    Weiden, Peter J.
    CNS SPECTRUMS, 2019, 24 (04) : 395 - 403
  • [23] The Incidence of Akathisia in the Treatment of Schizophrenia with Aripiprazole, Asenapine and Lurasidone: A Meta-Analysis
    Thomas, Jennifer E.
    Caballero, Joshua
    Harrington, Catherine A.
    CURRENT NEUROPHARMACOLOGY, 2015, 13 (05) : 681 - 691
  • [24] Evaluation of the safety and tolerability of Neoral and Sandimmune: A meta-analysis
    Shah, MB
    Martin, JE
    Schroeder, TJ
    First, MR
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) : 1697 - 1700
  • [25] Comparing Tolerability of Olanzapine in Schizophrenia and Affective Disorders: A Meta-Analysis
    Ross J. Baldessarini
    Drug Safety, 2012, 35 : 1183 - 1183
  • [26] Comparing Tolerability of Olanzapine in Schizophrenia and Affective DisordersA Meta-Analysis
    Hoda Moteshafi
    Simon Zhornitsky
    Sarah Brunelle
    Emmanuel Stip
    Drug Safety, 2012, 35 : 819 - 836
  • [27] Comparing Tolerability of Olanzapine in Schizophrenia and Affective Disorders A Meta-Analysis
    Moteshafi, Hoda
    Zhornitsky, Simon
    Brunelle, Sarah
    Stip, Emmanuel
    DRUG SAFETY, 2012, 35 (10) : 819 - 836
  • [28] Efficacy and safety of aripiprazole augmentation of clozapine in schizophrenia: A systematic review and meta-analysis of randomized-controlled trials
    Srisurapanont, Manit
    Suttajit, Sirijit
    Maneeton, Narong
    Maneeton, Benchalak
    JOURNAL OF PSYCHIATRIC RESEARCH, 2015, 62 : 38 - 47
  • [29] Metabolic safety and tolerability of ziprasidone vs. olanzapine in schizophrenia patients: Systematic review and meta-analysis
    Campbell, R. S.
    Xiong, Y.
    Erensen, J. G.
    Shah, N. R.
    Bernal, M. C.
    Miller, R. M.
    Sanders, K. N.
    Masters, E. T.
    Harnett, J.
    Kremer, C. M.
    VALUE IN HEALTH, 2008, 11 (03) : A113 - A113
  • [30] A review of the safety and tolerability of aripiprazole
    Pae, Chi-Un
    EXPERT OPINION ON DRUG SAFETY, 2009, 8 (03) : 373 - 386
12345